Predictors of decreased short- and long-term survival following open abdominal aortic aneurysm repair  by Nathan, Derek P. et al.
CLINICAL RESEARCH STUDIES
From the Society for Clinical Vascular Surgery
Predictors of decreased short- and long-term
survival following open abdominal aortic
aneurysm repair
Derek P. Nathan, MD,a Clayton J. Brinster, MD,a Benjamin M. Jackson, MD,b Grace J. Wang, MD,b
Jeffrey P. Carpenter, MD,c Ronald M. Fairman, MD,b and Edward Y. Woo, MD,b Philadelphia, Pa; and
Camden, NJ
Objectives: The purpose of this study was to identify predictors of decreased survival after open abdominal aortic aneurysm
(AAA) repair at a single university hospital.
Methods: Patients undergoing open AAA repair from June 2003 to June 2009 were identified. Primary outcomes were 30-day
and 5-year survival. Preoperative, intraoperative, and postoperative variables were assessed for their influence on outcomes
using univariate andmultivariate analysis, as appropriate. One- and 5-year survival were determined byKaplan-Meier analysis.
Results: Four hundred eight patients (289 men; 70.8%) with a mean age of 72.4  8.3 years underwent open AAA repair.
Sixty-seven patients (16.4%) underwent nonelective repair. The clamp site was infrarenal in 137 patients (33.6%), suprarenal
in 97 patients (23.8%), and supraceliac in 174 patients (42.6%). Thirty-day survival was 95.6%. One- and 5-year survival were
90.0%  1.5% and 65.1%  3.0%, respectively. Seventy-nine patients (19.4%) had decreased renal function postoperatively
compared to preoperatively, 71 patients (17.4%) sustained cardiac complications, and 45 patients (11.0%) sustained pulmo-
nary complications. Patients with chronic obstructive pulmonary disease (91.9% vs 97.2%; P  .004) and chronic renal
insufficiency (92.0% vs 98.3%; P .009) had decreased 30-day survival. Patients with chronic obstructive pulmonary disease
(55.8%  5.8% vs 67.3%  3.6%; P  .013), chronic renal insufficiency (51.2%  5.2% vs 72.8%  3.7%; P  .043), and
cerebrovascular disease (46.8% 7.4% vs 67.4% 3.4%; P .003) had decreased 5-year survival. Patients who had decreased
postoperative renal function (41.0% 7.4% vs 72.2% 3.4%;P .004), and patients who sustained pulmonary complications
(45.6%  8.8% vs 66.3%  3.3%; P  .042) had worse 5-year survival.
Conclusions: Open AAA repair can be done with low morbidity and mortality in the era of endovascular aneurysm repair.
Careful consideration should be given to preoperative optimization and perioperative care in patients with chronic obstructive
pulmonary disease, chronic renal insufficiency, and cerebrovascular disease. Postoperative decrease in renal function and
pulmonary complication portend decreased 5-year survival; strategies to ameliorate these factors should be sought. (J Vasc
Surg 2011;54:1237-43.)
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iEndovascular aneurysm repair (EVAR) has become the
treatment of choice for the majority of patients with aneu-
rysms of the infrarenal aorta.1 Compared to open abdominal
aortic aneurysm (AAA) repair, EVARhas a short-term survival
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doi:10.1016/j.jvs.2011.05.028enefit, as well as other perioperative advantages, such as
ecreased blood transfusion and shorter-length of hospital
tay.2,3 However, a significant number of patients with infra-
enal AAAs continue to undergo open repair. Open surgery
emains the definitive treatment for patients with infrarenal
AA of mycotic or connective tissue disease etiology. In
ddition, anatomic constraints, such as hostile aneurysm neck
nd difficult vascular access, continue to preclude stent graft
epair in a portion of patients with infrarenal AAA.4 Last,
lthough EVAR may have a short-term survival benefit over
pen AAA repair, this does not seem to translate into a
ong-term survival advantage.5,6
Meanwhile, open repair is still the standard of care atmost
nstitutions for juxtarenal, pararenal, and extent IV thoraco-
bdominal aortic aneurysms. In fact, the most common indi-
ation for open AAA repair in the current era of stent grafting
s involvement of the renal and visceral arteries.4While various
ff-label endovascular techniques, as well as devices approved
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November 20111238 Nathan et aloutside of the United States, have demonstrated the short-
term safety and efficacy of fenestrated or branched endograft
therapy for AAAs involving the renal and visceral arteries,7,8
long-term data regarding aneurysm sac behavior, and visceral
ostia patency remain lacking.
In order to assess the mortality and morbidity of open
AAA repair during the current era of EVAR, and in an effort to
evaluate predictors of decreased perioperative and long-term
survival after open repair, we analyzed a single institution’s
experience.
METHODS
A prospectively maintained vascular database was used to
retrospectively analyze data on patients (n  1123) who
underwent AAA repair between June 2003 and June 2009 at
the Hospital of the University of Pennsylvania. Of these pa-
tients, 715 (63.7%) underwent endovascular repair of infrare-
nal AAA, and 408 (36.3%) underwent open AAA repair. The
408 patients who underwent openAAA repair are the focus of
this study. The aneurysms treated included infrarenal, parare-
nal, suprarenal, and extent IV thoracoabdominal aortic aneu-
rysms (TAAAs). This study was conducted with the approval
of the institutional Human Research Ethics Committee.
Primary outcomes were 30-day and 5-year survival. Sec-
ondary outcomes included cardiac and pulmonary complica-
tions and decreased renal function. Cardiac complication was
defined as arrhythmia, ormyocardial ischemia or infarction, as
determined by electrocardiographic or laboratory evaluation.
Pulmonary complications included ventilator-dependent re-
spiratory failure, pneumonia, pleural effusion requiring drain-
age, or reintubation. Decreased renal function was defined as
worse postoperative renal function compared to preoperative
renal function, as measured by chronic kidney disease
stage.9-11 For example, a patient with preoperative stage II
chronic kidney disease (estimated glomerular filtration rate
[eGFR], 60-90) who postoperatively had stage III kidney
disease (eGFR 30-60) was classified as having decreased renal
function. Creatinine levels at discharge were used for calcula-
tion of postoperative renal function. Estimated eGFR was
determined by the Modification of Diet in Renal Disease
formula, and chronic renal insufficiency was defined as eGFR
less than 60.9-11
The influence of patient-related, disease-related, and
treatment-related variables on30-daymortality and secondary
outcomes were assessed using logistic regression for multivar-
iate analysis, and Pearson 2 and t test for univariate analysis.
Patient-related independent variables examined were age,
gender, race, statin usage, chronic renal insufficiency (CRI),
coronary artery disease (CAD), coronary revascularization,
cerebrovascular disease (CVD), chronic obstructive pulmo-
nary disease (COPD), and previous open or endovascular
AAA repair. Disease-related independent variables examined
were aneurysm size, timing of repair (elective, urgent, or
emergent), and proximal clamp site (infrarenal, suprarenal, or
supraceliac). Treatment-related independent variables exam-
ined were clamp time, retroperitoneal vs transperitoneal ap-
proach, the performance of a left renal artery bypass, the
administration of mannitol, and estimated blood loss (EBL). nong-term survival was determined with Kaplan-Meier life
able methods, and analyzed using log-rank (univariate) and
ox regression (multivariate) analysis. All tests of significance
ere at the P  .05 level, and all statistical analyses were
erformed with SPSS software (SPSS, Chicago, Ill).
ESULTS
Preoperative characteristics. Patient characteristics
re summarized in Table I. Sixty-seven patients (16.4%) un-
erwent nonelective repair: 24 patients (5.9%) underwent
mergent repair due to ruptured aneurysms, and 43 patients
10.5%) underwent urgent repair (within 24 hours of un-
lanned admission) due to symptomatic aneurysms. The re-
aining patients (n 341) underwent elective repair. Of the
43 patients who had undergone coronary revascularization,
6 (32.2%) underwent percutaneous coronary intervention
nd 97 (67.8%) underwent coronary artery bypass grafting.
ifty-five patients (13.5%) had undergone previous infrarenal
AA repair with EVAR (n  21) or open surgery (n  34).
ndications for open AAA repair after EVAR included eight
atients with proximal type I endoleak (six of whom failed
ttempts at endovascular salvage), five patients with graft
igration and aneurysm expansion, four patients with type II
ndoleak and aneurysm expansion (all of whom had failed
ultiple attempts at endovascular salvage), and four patients
ith aneurysmal degeneration proximal to the stent graft.12
he reason for open repair in the patients with previous open
AA repair was aneurysmal degeneration proximal to the
revious graft in all cases.
Operative details. The majority of patients (n 388;
5.1%) were not candidates for endovascular repair based
n anatomic criteria (Table II). Nine patients with ruptured
nfrarenal AAAs underwent open repair due to surgeon
reference. In addition, six patients underwent open repair
ue to mycotic or connective tissue disorder aneurysm
tiology, and five patients underwent open AAA repair due
o surgeon and patient preference.
Mean aneurysm size was 6.3  1.4 cm. A retroperito-
able I. Preoperative clinical details in patients
ndergoing open abdominal aortic aneurysm repair
Open AAA (n  408)
ender ratio (male:female) 289:119
ge, years 72.4  8.3
oronary artery disease 227 (55.6%)
Coronary revascularization 143 (63.0%)
Prior myocardial infarction 112 (49.3%)
RI 176 (43.1%)
OPD 123 (30.1%)
erebrovascular disease 73 (17.9%)
ypertension 327 (80.1%)
yperlipidemia 237 (58.1%)
iabetes 59 (14.5%)
trial fibrillation 57 (14.0%)
tatin usage 245 (60.0%)
AA, Abdominal aortic aneurysm; COPD, chronic obstructive pulmonary
isease; CRI, chronic renal insufficiency.eal approach (n 303; 74.3%) was used in the majority of
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Volume 54, Number 5 Nathan et al 1239cases, mostly due to the proximal extent of the aneurysm.
In total, 137 patients (33.6%) had infrarenal aortic clamps,
97 patients (23.8%) had suprarenal aortic clamps, and 174
patients (42.6%) had supraceliac aortic clamps. A tube graft
was used in 325 patients (79.7%), with the remaining 83
patients (20.3%) requiring a bifurcated graft. A transperi-
toneal approach was used in 59.0% (49/83) of the bifur-
cated graft cases.
Suprarenal and supraceliac ischemic times for patients
undergoing open AAA repair were 21.1  7.5 and 22.3 
9.0 minutes, respectively. Ischemic times were available for
237 (87.5%) of the 271 repairs requiring suprarenal or
supraceliac cross-clamping. In 114 patients (27.9%), after
construction of a beveled proximal anastomosis incorporat-
ing the ostia of the right renal artery and/or visceral arter-
ies, separate reimplantation of the left renal artery was
performed. This left renal artery bypass was performed with
a median additional left kidney ischemic time of 10 min-
utes.
Including ruptured aneurysms, mean EBL was 1.7 
1.4 liters, which differed by clamp site (infrarenal 1.0 0.5
L, suprarenal 1.4 1.3 L, and supraceliac 2.4 1.7 L; P
.001). At the discretion of the surgeon, 176 patients
(43.1%) received mannitol. Renal cooling was not per-
formed during any of the procedures.
Thirty-day survival. Overall 30-day survival was
95.6% for the entire cohort. In-hospital survival was also
95.6%. Neither overall 30-day survival (infrarenal 96.4%,
suprarenal 95.9%, and supraceliac 94.8%; P  .800), nor
elective 30-day survival (infrarenal 97.3%, suprarenal
96.6%, and supraceliac 96.4%; P .911) differed by clamp
site. Thirty-day survival did differ by timing of repair (elec-
tive 96.8%, urgent 93.0%, and emergent 83.3%; P  .035)
by multivariate analysis.
Compared to patients without these risk factors, pa-
tients with COPD (91.9% vs 97.2%; P  .004) and CRI
(92.0% vs 98.3%; P  .009) had decreased 30-day survival
by multivariate analysis. Neither a history of CAD, lack of
statin usage, EBL, nor the performance of renal bypass
predicted decreased 30-day survival. Post-hoc analysis
demonstrated that patients with CAD who had undergone
Table II. Primary indication for open repair (as opposed
to endovascular repair)
Open AAA
(n  408)
Involvement of renal or visceral arteries 271 (66.4%)
Hostile proximal neck 53 (13.0%)
Aortobiiliac aneurysm/insufficient distal
landing zone
42 (10.3%)
Difficult vascular access (aortic occlusion,
inadequate size of iliac vessels)
22 (5.4%)
Ruptured aneurysm 9 (2.2%)
Preference of patient and surgeon 6 (1.5%)
Mycotic or connective tissue disorder etiology 5 (1.2%)
AAA, Abdominal aortic aneurysm.coronary revascularization had an improved 30-day survival compared to patients with CAD who had not undergone
oronary revascularization (98.6% vs 91.7%; P  .026).
Long-term survival. Mean follow-up for patients was
8.1  24.8 months. Twelve percent of patients were lost
o follow-up. Mean survival was 65.3  1.8 months. One-
nd 5-year survival were 90.0%  1.5% and 65.1%  3.0%,
espectively (Fig 1). Clamp site (infrarenal 73.9%  4.5%,
uprarenal 64.5%  6.8%, supraceliac 52.9%  5.3%; P 
001), and statin usage (71.1%  3.7% vs 57.2%  5.1%;
 .005) predicted 5-year survival by univariate but not
ultivariate analysis. Timing of repair (elective 68.3% 
.4%, urgent 45.0% 9.1%, and emergent 43.2% 11.5%;
 .011) predicted 5-year survival by multivariate analysis.
Patients with COPD (55.8%  5.8% vs 67.3%  3.6%;
 .013), CRI (51.2% 5.2% vs 72.8% 3.7%; P .043;
ig 2, A), and CVD (46.8%  7.4% vs 67.4%  3.4%; P 
003) had worse 5-year survival by multivariate analysis. In
ddition, patients who had worse renal function postoper-
tively (41.0%  7.4% vs 72.2%  3.4%; P  .004; Fig 2,
), and patients who sustained pulmonary complications
45.6%  8.8% vs 66.3%  3.3%; P  .042) had poorer
-year survival by multivariate analysis. Neither a history of
AD nor cardiac complication predicted decreased Kaplan-
eier survival.
Major complications. Seventy-nine patients (19.4%)
ustained worsened renal function postoperatively; of
hese, seven patients (1.7%) developed worsening renal
unction requiring long-term dialysis. Overall, the mean
reoperative serum creatinine was 1.30  0.86 mg/dL,
nd the mean discharge serum creatinine was 1.32  0.94
g/dL (P  .510). While renal ischemic time did not
redict decreased renal function, more proximal clamp site
id predict worsened renal function by univariate (P 
001) but not multivariate analysis (P  .589).
Cardiac complications occurred in 71 patients (17.4%).
wenty-nine patients (7.1%) sustained myocardial ischemia
r infarction, and 42 patients (10.3%) sustained arrhyth-
ias, most commonly atrial fibrillation. Forty-five patients
11.0%) sustained pulmonary complications. Additional
omplications included 12 patients (2.9%) requiring return
o the operating room for bleeding, eight patients (2.0%)
equiring intervention for limb ischemia, four patients
1.0%) requiring laparotomy for intestinal ischemia, and
wo patients (0.5%) sustaining cerebrovascular accidents.
hree patients (0.7%), all of whom had supraceliac cross-
lamps, sustained spinal cord ischemia: one patient sus-
ained an intraoperative cardiac arrest and awoke with
araplegia, another patient thrombosed his/her aortic graft
ostoperatively leading to paraplegia and multisystem or-
an failure, and the last patient had an extent type IV TAAA
epair complicated by paraparesis that resolved.
ISCUSSION
A large contemporary, single-center experience with
pen AAA repair has been presented. The 30-day and
-year survival rates in this series compare well with those
eported in the literature (Table III).5-6,13-20 The current
ohort includes patients who underwent emergent and
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which predicted decreased 30-day and long-term survival
by multivariate analysis. While patients with symptomatic
AAAs that undergo urgent repair do not have the physio-
logical derangements of patients with ruptured aneu-
rysms,21 urgent operation does preclude optimization of
cardiovascular and pulmonary risk factors.22
It is interesting that more proximal clamp site did not
predict decreased 30-day survival, but did predict decreased
5-year survival by univariate analysis. Other studies have
found that more proximal clamp placement results in de-
creased perioperative survival.15,23 Cross-clamping above
the renal arteries or celiac artery poses technical challenges,
including high retroperitoneal access and the performance
of renal bypass, which often translate to increased blood
loss and operative duration, and greater rates of renal
insufficiency, bowel ischemia, and perioperative mor-
tality.15,23-28 Myers et al29 demonstrated that clamping
above the renal arteries results in decreased creatinine clear-
ance, while more proximal clamping above the superior
mesenteric artery induces mesenteric ischemia/reperfusion
injury and further deterioration of renal function. Kidney
dysfunction has been shown to be an independent risk
factor for long-term mortality.10,30-32 The finding that
more proximal cross-clamping predicts decreased renal
function may explain the association between more proxi-
mal clamp site and decreased 5-year survival.
The authors believe that several technical aspects are
important in achieving the results herein reported. First,
manipulation of visceral and renal vessels is kept to a mini-
mum in order to prevent injury and subsequent thrombosis
Fig 1. Overall survival curve using Kaplan-Meier estima
repair (n  408).or bleeding. In this context, visceral and renal vessels are larely dissected out and occluded distally while the anasto-
osis is performed. While this may result in increased
lood loss due to back-bleeding, we find that most of this
an be recovered through the use of cell saver. Second,
pen AAA repair is always done in a manner to minimize
isceral and renal ischemic time. In the case of an AAA
nvolving the renal and visceral arteries, whenever possible,
he celiac artery, superior mesenteric artery, and/or right
enal artery are incorporated into a beveled proximal anas-
omosis. If a left renal artery bypass is necessary, it is
erformed immediately after the proximal anastomosis.
ast, preoperative optimization is crucial, as the majority of
atients in the current study had at least one of the risk
actors of CAD, COPD, and CRI, which have been shown
o decrease survival.23 All patients evaluated for elective
pen AAA repair underwent preoperative cardiac imaging,
ncluding a stress test and echocardiogram. Patients who
emonstrated reversible ischemia underwent cardiac cath-
terization and correction of underlying coronary lesions.
f note, pulmonary function testing is not routinely per-
ormed as we find that it is often effort-dependent and may
nderestimate the patient’s ability to tolerate a procedure.
atients who were active smokers were instructed to quit
moking.
Recently, several studies have highlighted the impor-
ance of hospital and surgeon volume in outcomes after
pen AAA repair.33,34 Landon et al33 investigated the
elationship between institutional volume and periopera-
ive mortality, and found a steady increase in survival with
ncreasing volume of open repair. In their study, hospitals
hat performed over 50 open AAA repairs per year had
r patients undergoing open abdominal aortic aneurysmtes foower perioperative mortality than lower volume centers. In
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Volume 54, Number 5 Nathan et al 1241another study, McPhee et al34 showed that surgeon vol-
ume, not hospital volume, was the primary determinant of
in-hospital mortality after open AAA repair. Surgeons who
performed more than nine open AAA repairs a year had
decreased in-hospital mortality compared to lower volume
surgeons.34 The results of these studies support the region-
alization of AAA repair not only to high-volume hospitals,
but also to high-volume surgeons.
Patients who sustained worse renal function postoper-
atively had poorer 5-year survival, which is confirmed by
recent studies.30-32 Bihorac et al30 found that kidney injury
after major abdominal and cardiothoracic surgery was asso-
ciated with an independent long-term risk of death, and
concluded that kidney injury should no longer be viewed
only as an indicator of overall severity of illness, but also as
Fig 2. A,Kaplan-Meier survival curve for patients under
estimated glomerular filtration rate (eGFR) less than or
undergoing open abdominal aortic aneurysm repair by san independent predictor of long-term outcome. Interro- tation of the National Surgical Quality Improvement Pro-
ram database in the Veterans Administration confirmed
hat postoperative complications, such as decreased renal
unction, could be more important than preoperative and
ntraoperative factors in determining long-term survival.32
his National Surgical Quality Improvement Program
tudy showed that the negative effect of postoperative
omplications on long-term survival was not due solely to
ncreased 30-day mortality.32 This finding is supported by a
ualitative assessment of Fig 2, B, which demonstrates that
he Kaplan-Meier survival curves of patients who had stable
s worse postoperative renal function continue to diverge
ast 30 days. Although it is not certain how postoperative
enal dysfunction results in decreased long-term survival, it
eems to lead to ongoing progressive kidney damage and
open abdominal aortic aneurysm repair by preoperative
er than 60. B, Kaplan-Meier survival curve for patients
vs worse postoperative renal function.going
greathe development of chronic kidney disease, which is an
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and death.10,30-32
Strategies to prevent or mitigate kidney injury with
open AAA repair may, therefore, improve outcomes. Con-
tinuous cold perfusion of the kidneys during open AAA
repair requiring suprarenal clamping has been shown to
reduce postoperative renal complications.35,36 In addition,
statin usage has been associated with improved recovery of
renal function in patients who developed postoperative
kidney injury and with improved long-term survival after
vascular surgery.37 Consistent with these results, we found
that statin usage predicted improved 5-year survival. Al-
though these strategies may be useful adjuncts, minimizing
ischemia to the kidneys by limiting clamp time remains the
most important strategy in preventing postoperative de-
crease in renal function. In addition, the performance of
renal artery endarterectomy at the time of aneurysm repair
has been shown to improve renal function postopera-
tively.16
Neither a history of CAD nor cardiac complication
predicted decreased survival. Several factors may explain
this finding. First, the majority of our patients were on
statins preoperatively. In a randomized control trial,
Schouten et al22 demonstrated that statin usage before
vascular surgery decreased postoperative myocardial isch-
emia and death from cardiovascular causes. Second, post-
hoc analysis showed that patients with CAD who had
undergone coronary revascularization had improved 30-
day survival. While the latter findings do not coincide with
the results of several randomized control trials in which
coronary revascularization was performed in anticipation of
major vascular surgery, it is possible that in this cohort of
patients, coronary revascularization protected against post-
operative myocardial infarction and death.38-40
Finally, given the morbidity and mortality associated
Table III. Summary of survival in contemporary studies
of open repair of abdominal aortic aneurysms
No. of
patients
Thirty-day
survival
Long-term
survival
Infrarenal aortic clampa
Current series 137 97.3% 76.1% at 5 years
DREAM trial5,13 174 95.4% 69.9% at 6 years
EVAR trial6 626 95.7% 54% at 8 years
Chong et al14 849 98.8% 69.1% at 5 years
Landry et al15 103 97.1% Not reported
Suprarenal aortic clampa
Current series 97 96.6% 69.1% at 5 years
Chong et al14 171 98.2% 67.7% at 5 years
Landry et al15 82 93.9% Not reported
Supraceliac aortic clamp
Current series 174 94.8% 52.9% at 5 years
Nathan et alb,16 108 94.4% 50.0% at 5 years
Coselli et alb,17,18 329 96.4% 65.3% at 5 years
Kieffer et alb,19 171 86.6% Not reported
Richards et ala,20 53 94.0% 78.0% at 3 years
aElective results.
bExtent type IV thoracoabdominal aortic aneurysms.with open repair of AAAs involving the visceral arteries,everal studies have reported on the use of endovascular
herapy to treat this complicated disease process.7,8 Green-
erg et al7 assessed the use of fenestrated endovascular
rafts to treat juxtarenal AAAs in 30 patients, and reported
ight renal events and two deaths over a follow-up of 2
ears. Haulon et al8 reported on 80 patients who under-
ent elective fenestrated aortic endograft placement for
uxtarenal, suprarenal, and extent type IV TAAAs, and
eported a 1- and 2-year survival of 92%. While these studies
ighlight the intermediate safety of elective endovascular re-
air of AAAs involving the visceral arteries, long-term
ollow-up of aneurysm sac behavior, visceral artery patency,
nd aneurysm-related and overall mortality remains lacking.
In summary, this study demonstrates that open AAA
epair can be performed with acceptable morbidity and
ortality. CRI and COPD predicted decreased 30-day
urvival, while CRI, COPD, and CVD predicted decreased
-year survival. Postoperative decrease in renal function
nd pulmonary complication resulted in decreased 5-year
urvival. These findings suggest that careful consideration
hould be given to preoperative optimization and periop-
rative care in patients with COPD, CRI, and CVD. Last,
nvestigation of strategies to ameliorate postoperative renal
ysfunction and pulmonary complications is warranted.
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